Neon Bloom, Inc. (NBCO)
New York City, NY, US
Neon Bloom, Inc. functions as a principal investment firm, with a core focus on acquiring enterprises. Established in 2015, this New York-based company primarily directs its capital towards groundbreaking agricultural solutions and the related technological products and services that support them, operating on an international scale.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.06% | +4.06% | -17.47% | +6.85% | +10.46% | -27.47% | -94.85% | -98.25% | -99.93% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Biotechnology: +1.6%-85.7% Q4'25: -72.9% (vs Q3'24)
-
EPS growth Biotechnology: +29.7%+112.6% ★ Q4'25: +226.9% (vs Q3'24)
-
FCF margin FCF growth · Biotechnology: +16.2%-10.9% Q4'25: +14.3% (vs Q3'24)
-
EBIT margin Biotechnology: +0.0%-10.5% Q4'25: +8.8% (vs Q3'24)
-
ROIC Biotechnology: -16.1%— Q4'25: -28.3% (vs Q3'24)
-
Share dilution Biotechnology: -3.4%+74.6% Q4'25: 0.0% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.69× Q4'25: 0.49× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ID – Not applicable | 687.0K | 8.53% | 687.0K | — | 687.0K | — | CO | Virgin Islands | 2010-01-12 | ↗ |
| 2 | ID. – Not applicable | 56.0K | 1.00% | 687.0K | — | 687.0K | — | CO | Virgin Islands | 2008-10-22 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2008 | Zahir Teja President, CEO, Director | 160.0K | — | — | — | — | — | 160.0K | 0.00% | ↗ |
| 2 | 2008 | Neev Nissenson VP, Secretary, Treasurer, CFO and Director | 109.0K | — | — | — | — | — | 109.0K | 0.00% | ↗ |
| 3 | 2008 | Teja N. Shariff Former CFO, Treasurer and CAO | 60.0K | — | — | — | — | — | 60.0K | 0.00% | ↗ |
| 4 | 2007 | Zahir Teja President, CEO, Director | 120.0K | — | — | 178.2K | — | — | 298.2K | 59.76% | ↗ |
| 5 | 2007 | Neev Nissenson VP, Secretary, Treasurer, CFO and Director | 50.0K | — | — | 89.1K | — | — | 139.1K | 64.05% | ↗ |
| 6 | 2007 | Neev Nissenson VP, Secretary, Director | 50.0K | — | — | 89.1K | — | — | 139.1K | 64.05% | ↗ |
| 7 | 2007 | Teja N. Shariff CFO, Treasurer, CAO | 40.0K | — | — | — | — | — | 40.0K | 0.00% | ↗ |
| 8 | 2007 | Teja N. Shariff Former CFO, Treasurer and CAO | 40.0K | — | — | — | — | — | 40.0K | 0.00% | ↗ |
| 9 | 2006 | Zahir Teja President, CEO, Director | 120.0K | — | — | — | — | — | 120.0K | 0.00% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Grand | Secretary | 23.6K | male |
| Greg Bauer | Chief Executive Officer & Director | — | male |
| Daniel Levinson | Associate | — | male |
| Robyn Frick | President | — | female |
| Steven Salsburg | Treasurer | — | — |
| Walter Tabaschek | Chief Financial Officer & Chief Operating Officer | — | male |
| Paul De Kleijn | Chief Science Advisor | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NBCO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
